Molecular pathways involved in the development and progression of NAFLD include alterations in lipid metabolism, insulin signaling, insulin resistance, oxidative stress, defective gut microbiome, and inflammation. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.